ALXN
Alexion Pharmaceuticals Inc
Price:  
182.50 
USD
Volume:  
15,135,410.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Alexion EV/EBITDA

13.2%
Upside

As of 2024-03-03, the EV/EBITDA ratio of Alexion Pharmaceuticals Inc (ALXN) is 12.38. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Alexion's latest enterprise value is 39,557.69 mil USD. Alexion's TTM EBITDA according to its financial statements is 3,196.40 mil USD. Dividing these 2 quantities gives us the above Alexion EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 15.7x - 26.1x 20.6x
Forward P/E multiples 22.0x - 31.2x 26.1x
Fair Price 94.75 - 379.82 206.63
Upside -48.1% - 108.1% 13.2%
182.50 USD
Stock Price
206.63 USD
Fair Price

Alexion EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA